Results for "ruxolitinib" | Prospecte.ro

Medication leaflets

JAKAVI 10mg tablets EUROPHARM ORIGINAL MEDICINE

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Price

14756.79 RON

List

C2

Prescription

P-RF
JAKAVI 15mg tablets EUROPHARM ORIGINAL MEDICINE

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Price

14370.57 RON

List

C2

Prescription

P-RF
JAKAVI 20mg tablets EUROPHARM ORIGINAL MEDICINE

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Price

14370.57 RON

List

C2

Prescription

P-RF
JAKAVI 5mg tablets EUROPHARM ORIGINAL MEDICINE

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Price

7262.33 RON

List

C2

Prescription

P-RF
RUXOLITINIB MSN 10mg tablets MSN LABS EUROPE LIMI

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-6L
RUXOLITINIB MSN 15mg tablets MSN LABS EUROPE LIMI

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-6L
RUXOLITINIB MSN 20mg tablets MSN LABS EUROPE LIMI

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-6L
RUXOLITINIB MSN 5mg tablets MSN LABS EUROPE LIMI

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-6L
RUXOLITINIB SANDOZ 10mg tablets SANPHASRL

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
RUXOLITINIB SANDOZ 15mg tablets SANPHASRL

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
RUXOLITINIB SANDOZ 20mg tablets SANPHASRL

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
RUXOLITINIB SANDOZ 5mg tablets SANPHASRL

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
XORUTEN 10mg tablets EGIS

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
XORUTEN 15mg tablets EGIS

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
XORUTEN 20mg tablets EGIS

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF
XORUTEN 5mg tablets EGIS

Chemical substance: ruxolitinib

ATC code: L01EJ01 • Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors

Prescription

P-RF

Results for the substance ruxolitinib

ruxolitinib

Indicated for: cancer

L01EJ01 Antineoplastic and immunomodulating agents | Protein kinase inhibitors | Janus-associated kinase (JAK) inhibitors